Original Article

Published: Sep 13, 2025 | DOI: 10.24911/ejmcr.9-2252

Primary adrenal malignancies in Oman in the last decade (2014-2023); single tertiary hospital experience


Authors: Rudainy Kaddoura orcid logo , Sawab Al Hosni , Amru Ahmed Redha


Article Info

Authors

Rudainy Kaddoura

Department of General Surgery, The Royal Hospital, Muscat, Oman

orcid logo ORCID

Sawab Al Hosni

Senior Surgery Resident, Oman Medical Specialty Board, Muscat, Oman

Amru Ahmed Redha

General Surgery Department, The Royal Hospital, Muscat, Oman

Publication History

Received: June 09, 2025

Accepted: August 18, 2025

Published: September 13, 2025


Abstract


Background: Adrenal malignancy is a rare entity of diseases that has a low incidence, vague symptoms, and variable prognosis. Due to its rarity, case series studies from around the world can contribute to a better understanding of the disease.
Aims and Objectives: To analyze the similarities and differences in this adrenal malignancy spectrum within the Middle East.
Settings: This retrospective case series was conducted at the Royal Hospital, Muscat, Oman.
Methods: The medical records of the patients diagnosed with primary adrenal malignancies were reviewed from January 2014 to December 2023.
Results: A total of 15 patients with a mean age of 52 years were included, with a male-to-female ratio of 1:2.7. The majority of patients (80%) had a personal medical history, and the most common condition was hypertension. Four patients (26.6%) presented with abdominal pain that required computed tomography imaging to determine the cause. Left-sided malignancy was predominant (60%); however, the majority of male patients had right-sided tumors (75%) (p-value = 0.235). The largest tumor measured 169 mm, with no statistically significant difference in tumor size between males and females: 87.3 ± 10.6 mm in males
versus 91.8 ± 47.4 mm in females (p-value = 0.77). Laboratory investigations revealed that 53% of the patients had elevated hormone levels, including aldosterone, cortisol, testosterone, and metanephrines.
Conclusion: With the rarity of this spectrum of diseases, more studies are needed for a better evaluation of its impact on the community. Hopefully, more advanced technology, especially at the molecular level, can allow a better understanding of its
behavior.


Keywords: Endocrine surgery, adrenal, cancer, pheochromocytoma